T cells from AML patients had a decrease in the percentage of LAG-3+ TIM-3+ PD-1− cells and an increased percentage of LAG-3− TIM-3− PD-1+ cells compared with healthy donors. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.